Investor Centre

Recent Announcements

12-Dec-2017 – A profitable and growing market leader in nuclear lung imaging (1.55MB) Download
20-Nov-2017 – Change of Director’s Interest Notice (594.97KB) Download
18-Oct-2017 – Cyclopharm CEO Presentation at Australian MicroCap Conference (678.12KB) Download
26-Sep-2017 – Cyclopharm’s USFDA Technegas Clinical Trial – Patient Enrolment Underway (492.13KB) Download
  • All 2017 Announcements
    12-Dec-2017 – A profitable and growing market leader in nuclear lung imaging (1.55MB) Download
    20-Nov-2017 – Change of Director’s Interest Notice (594.97KB) Download
    18-Oct-2017 – Cyclopharm CEO Presentation at Australian MicroCap Conference (678.12KB) Download
     2017 Half Yearly Report and Accounts (1.19MB) Download
  • Analyst Reviews
    29-Sep-2017 – Cyclopharm (CYC) First Patients In US Pivotal Study Enrolled. (Buy, PT$1.13) (439.69KB) Download
    30-Aug-2017 – Bell Potter Review (479.98KB) Download
    17-Jul-2017 – Bell Potter Review (986.41KB) Download

Whether you are a shareholder or not, you can subscribe to receive all company announcements through our email alerts service.

To join email alerts, simply fill in your details using the form below and nominate which announcements you would like to receive.

Your privacy is important to us. If you no longer want to receive email alerts, use the unsubscribe link. If you are a shareholder and want to change your details or check your holdings, then use the share registry information on the contact us page.

Email Alerts

Which of the following groups do you best fit?

Do you currently hold shares in Cyclopharm?

YesNo

If yes, how would you like to receive company information?

EmailMailBoth